Contact Us

Fmr. FDA Commissioner Dr. Scott Gottlieb on the secondary benefits of weight loss drugs

Thought Leader: Scott Gottlieb
January 2, 2024

Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss the state of the weight loss drug developments, whether insurance overage of these drugs will be broadened in the future, drug development outlook in 2024, and more.

Subscribe to the WWSG newsletter.

Check Availability

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

0
Speaker List
Share My List